Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial (NAIL-IT)
view all Clinical Trials
Overview
Evaluation of safety and thrombolytic effect of ascending doses of TS23 in subjects with intermediate-risk (sub-massive) acute pulmonary embolism (PE).
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.